Skip to main content
Jordan Dunitz, MD, Pulmonology, Minneapolis, MN, M Health Fairview University of Minnesota Medical Center

JordanMatthewDunitzMD

Pulmonology Minneapolis, MN

Critical Care Medicine, Cystic Fibrosis, Lung Transplantation Medicine, Pleural Disease

UMPhysicians

Dr. Dunitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Dunitz's full profile

Already have an account?

  • Office

    University Of Minnesota Physicians
    516 Delaware Street Se, Pwb Second Floor, Clinic 2a
    Minneapolis, MN 55455
    Phone+1 612-626-6100
  • Is this information wrong?

Education & Training

  • University of Minnesota
    University of MinnesotaFellowship, Pulmonary Disease and Critical Care Medicine, 1991 - 1994
  • University of Minnesota
    University of MinnesotaResidency, Internal Medicine, 1988 - 1991
  • Stony Brook University Health Sciences Center School of Medicine
    Stony Brook University Health Sciences Center School of MedicineClass of 1988

Certifications & Licensure

  • MN State Medical License
    MN State Medical License 1993 - 2025

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
  • Super Doctor SuperDoctors.com

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • New FDA-Approved Treatment for Cystic Fibrosis Gives Hope to Thousands
    New FDA-Approved Treatment for Cystic Fibrosis Gives Hope to ThousandsOctober 22nd, 2019

Grant Support

  • A Phase 3, International, Multi-Center, Randomized, Double-Blind, Placebo-ControNational Center For Research Resources2009
  • A Phase 2A, Randomized, Double-Blind, Placebo-Controlled Study Of VX-770 To EvalNational Center For Research Resources2008–2009
  • 08-108: Denufosol Tetrasodium Inhalatoin Solution In Mild CF Lung DiseaseNational Center For Research Resources2007–2009
  • A Phase 1, OPEN Label Safety And Tolerability Study Of Oral Theraclec In SubjectNational Center For Research Resources2004

Hospital Affiliations